ArticleBioinformatics (Oxford, England)2026
Reconstructing and comparing signal transduction networks from single-cell protein quantification data.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Cancer drug response and resistance: molecular mechanisms and combating strategies.Signal transduction and targeted therapy · 2026Review
- Cell-State-Specific Drug Responses are Associated With Differences in Signaling Network Wiring.Molecular & cellular proteomics : MCP · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
motivationSignal transduction networks regulate many essential biological processes and are frequently aberrated in diseases such as cancer. A mechanistic understanding of such networks, and how they differ between cell populations, is essential to design effective treatment strategies. Typically, such networks are computationally reconstructed based on systematic perturbation experiments, followed by quantification of signaling protein activity. Recent technological advances now allow for the quantification of the activity of many (signaling) proteins simultaneously in single cells. This makes it feasible to reconstruct or quantify signaling networks without performing systematic perturbations.
resultsHere, we introduce single-cell modular response analysis (scMRA) and single-cell comparative network reconstruction (scCNR) to derive signal transduction networks by exploiting the heterogeneity of single-cell (phospho-)protein measurements. The methods treat stochastic variation in total protein abundances as natural perturbation experiments, whose effects propagate through the network and hence facilitate the reconstruction and quantification of the underlying signaling network. scCNR reconstructs cell population-specific networks, where cells from different populations have the same underlying topology, but the interaction strengths can differ between populations. We extensively validated scMRA and scCNR on simulated data, and applied it to unpublished data of (phospho-)protein measurements of EGFR-inhibitor-treated keratinocytes to recover signaling differences downstream of EGFR. scCNR will help to unravel the mechanistic signaling differences between cell populations, and will subsequently guide the development of well-informed treatment strategies. AVAILABILITY AND IMPLEMENTATION: The code used for scCNR in this study has been deposited on Zenodo https://doi.org/10.5281/zenodo.17600937 and is also available as a Python module at https://github.com/ibivu/scmra. Additionally, data and code to reproduce all figures is available at https://github.com/tstohn/scmra_analysis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.